DNA-Based Vaccines Mimicking Viruses Show Promise in Inducing Strong Immune Response
Source-MIT-News Innovative Vaccine Development Researchers from MIT and the Ragon Institute of MGH, MIT, and Harvard have devised a groundbreaking vaccine strategy utilizing DNA-based vaccines that mimic viruses to provoke a potent immune response against SARS-CoV-2, the virus responsible for COVID-19. This novel vaccine approach, detailed in a study published in Nature Communications, leverages a DNA scaffold carrying multiple copies of a viral antigen to mimic the structure of the virus itself. Unlike conventional protein-based vaccines, this DNA-based vaccine aims to target specific viral antigens without eliciting an unnecessary immune response to the scaffold. Key Findings and Significance In the study conducted on mice, the researchers observed that the DNA scaffold did not trigger an immune response, allowing the immune system to focus solely on generating antibodies against the target antigen—the receptor-binding protein of the SARS-CoV-2 spike protein. This focused immune res...